Packaged Foods
Compare Stocks
2 / 10Stock Comparison
HCWC vs BTMD
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Care Facilities
HCWC vs BTMD — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Packaged Foods | Medical - Care Facilities |
| Market Cap | $4M | $92M |
| Revenue (TTM) | $78M | $188M |
| Net Income (TTM) | $-4M | $16M |
| Gross Margin | 39.6% | 70.1% |
| Operating Margin | -1.5% | 15.4% |
| Forward P/E | — | 2.8x |
| Total Debt | $26M | $110M |
| Cash & Equiv. | $2M | $24M |
HCWC vs BTMD — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Sep 24 | May 26 | Return |
|---|---|---|---|
| Healthy Choice Well… (HCWC) | 100 | 11.4 | -88.6% |
| biote Corp. (BTMD) | 100 | 37.5 | -62.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: HCWC vs BTMD
Each card shows where this stock fits in a portfolio — not just who wins on paper.
HCWC carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- beta 1.66
- Rev growth 24.6%, EPS growth 55.6%, 3Y rev CAGR 83.5%
- Lower volatility, beta 1.66, current ratio 0.81x
BTMD is the clearest fit if your priority is long-term compounding.
- -79.2% 10Y total return vs HCWC's -94.6%
- 8.3% margin vs HCWC's -5.4%
- 2.3% yield; the other pay no meaningful dividend
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 24.6% revenue growth vs BTMD's -2.5% | |
| Quality / Margins | 8.3% margin vs HCWC's -5.4% | |
| Stability / Safety | Beta 1.66 vs BTMD's 1.73 | |
| Dividends | 2.3% yield; the other pay no meaningful dividend | |
| Momentum (1Y) | -24.8% vs BTMD's -37.4% | |
| Efficiency (ROA) | 15.1% ROA vs HCWC's -11.7%, ROIC 11.3% vs -5.6% |
HCWC vs BTMD — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
HCWC vs BTMD — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
BTMD leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
BTMD is the larger business by revenue, generating $188M annually — 2.4x HCWC's $78M. BTMD is the more profitable business, keeping 8.3% of every revenue dollar as net income compared to HCWC's -5.4%. On growth, HCWC holds the edge at +29.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $78M | $188M |
| EBITDAEarnings before interest/tax | $2M | $32M |
| Net IncomeAfter-tax profit | -$4M | $16M |
| Free Cash FlowCash after capex | $2M | $29M |
| Gross MarginGross profit ÷ Revenue | +39.6% | +70.1% |
| Operating MarginEBIT ÷ Revenue | -1.5% | +15.4% |
| Net MarginNet income ÷ Revenue | -5.4% | +8.3% |
| FCF MarginFCF ÷ Revenue | +2.2% | +15.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | +29.5% | -8.3% |
| EPS Growth (YoY)Latest quarter vs prior year | +56.0% | -83.8% |
Valuation Metrics
HCWC leads this category, winning 2 of 2 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $4M | $92M |
| Enterprise ValueMkt cap + debt − cash | $27M | $178M |
| Trailing P/EPrice ÷ TTM EPS | -0.59x | 2.82x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | 4.54x |
| Price / SalesMarket cap ÷ Revenue | 0.05x | 0.48x |
| Price / BookPrice ÷ Book value/share | 1.13x | — |
| Price / FCFMarket cap ÷ FCF | — | 3.05x |
Profitability & Efficiency
BTMD leads this category, winning 5 of 7 comparable metrics.
Profitability & Efficiency
On the Piotroski fundamental quality scale (0–9), BTMD scores 6/9 vs HCWC's 5/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -73.9% | — |
| ROA (TTM)Return on assets | -11.7% | +15.1% |
| ROICReturn on invested capital | -5.6% | +11.3% |
| ROCEReturn on capital employed | -8.5% | +53.3% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 |
| Debt / EquityFinancial leverage | 10.72x | — |
| Net DebtTotal debt minus cash | $23M | $86M |
| Cash & Equiv.Liquid assets | $2M | $24M |
| Total DebtShort + long-term debt | $26M | $110M |
| Interest CoverageEBIT ÷ Interest expense | -1.15x | 3.02x |
Total Returns (Dividends Reinvested)
BTMD leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in BTMD five years ago would be worth $2,090 today (with dividends reinvested), compared to $544 for HCWC. Over the past 12 months, HCWC leads with a -24.8% total return vs BTMD's -37.4%. The 3-year compound annual growth rate (CAGR) favors BTMD at -32.8% vs HCWC's -62.1% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +1.5% | -15.4% |
| 1-Year ReturnPast 12 months | -24.8% | -37.4% |
| 3-Year ReturnCumulative with dividends | -94.6% | -69.7% |
| 5-Year ReturnCumulative with dividends | -94.6% | -79.1% |
| 10-Year ReturnCumulative with dividends | -94.6% | -79.2% |
| CAGR (3Y)Annualised 3-year return | -62.1% | -32.8% |
Risk & Volatility
Evenly matched — HCWC and BTMD each lead in 1 of 2 comparable metrics.
Risk & Volatility
HCWC is the less volatile stock with a 1.66 beta — it tends to amplify market swings less than BTMD's 1.73 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BTMD currently trades 44.0% from its 52-week high vs HCWC's 29.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.66x | 1.73x |
| 52-Week HighHighest price in past year | $0.98 | $4.75 |
| 52-Week LowLowest price in past year | $0.22 | $1.27 |
| % of 52W HighCurrent price vs 52-week peak | +29.1% | +44.0% |
| RSI (14)Momentum oscillator 0–100 | 56.8 | 62.2 |
| Avg Volume (50D)Average daily shares traded | 500K | 265K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
BTMD is the only dividend payer here at 2.25% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — |
| Price TargetConsensus 12-month target | — | — |
| # AnalystsCovering analysts | — | — |
| Dividend YieldAnnual dividend ÷ price | — | +2.3% |
| Dividend StreakConsecutive years of raises | — | 0 |
| Dividend / ShareAnnual DPS | — | $0.05 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +3.7% |
BTMD leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). HCWC leads in 1 (Valuation Metrics). 1 tied.
HCWC vs BTMD: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is HCWC or BTMD a better buy right now?
For growth investors, Healthy Choice Wellness Corp.
(HCWC) is the stronger pick with 24. 6% revenue growth year-over-year, versus -2. 5% for biote Corp. (BTMD). biote Corp. (BTMD) offers the better valuation at 2. 8x trailing P/E, making it the more compelling value choice. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — HCWC or BTMD?
Over the past 5 years, biote Corp.
(BTMD) delivered a total return of -79. 1%, compared to -94. 6% for Healthy Choice Wellness Corp. (HCWC). Over 10 years, the gap is even starker: BTMD returned -79. 2% versus HCWC's -94. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — HCWC or BTMD?
By beta (market sensitivity over 5 years), Healthy Choice Wellness Corp.
(HCWC) is the lower-risk stock at 1. 66β versus biote Corp. 's 1. 73β — meaning BTMD is approximately 4% more volatile than HCWC relative to the S&P 500.
04Which is growing faster — HCWC or BTMD?
By revenue growth (latest reported year), Healthy Choice Wellness Corp.
(HCWC) is pulling ahead at 24. 6% versus -2. 5% for biote Corp. (BTMD). On earnings-per-share growth, the picture is similar: biote Corp. grew EPS 703. 5% year-over-year, compared to 55. 6% for Healthy Choice Wellness Corp.. Over a 3-year CAGR, HCWC leads at 83. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — HCWC or BTMD?
biote Corp.
(BTMD) is the more profitable company, earning 14. 1% net margin versus -6. 5% for Healthy Choice Wellness Corp. — meaning it keeps 14. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BTMD leads at 18. 5% versus -2. 6% for HCWC. At the gross margin level — before operating expenses — BTMD leads at 71. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — HCWC or BTMD?
In this comparison, BTMD (2.
3% yield) pays a dividend. HCWC does not pay a meaningful dividend and should not be held primarily for income.
07Is HCWC or BTMD better for a retirement portfolio?
For long-horizon retirement investors, biote Corp.
(BTMD) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (2. 3% yield). Healthy Choice Wellness Corp. (HCWC) carries a higher beta of 1. 66 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (BTMD: -79. 2%, HCWC: -94. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between HCWC and BTMD?
These companies operate in different sectors (HCWC (Consumer Defensive) and BTMD (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: HCWC is a small-cap high-growth stock; BTMD is a small-cap deep-value stock. BTMD pays a dividend while HCWC does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.